CLINICAL PHARMACOKINETICS OF METHOTREXATE

被引：215
作者：
SHEN, DD
AZARNOFF, DL
机构：
[1] UNIV KANSAS,MED CTR,CTR CLIN PHARMACOL & TOXICOL,DEPT PHARMACOL,KANSAS CITY,KS 66103
[2] UNIV KANSAS,MED CTR,CTR CLIN PHARMACOL & TOXICOL,DEPT MED,KANSAS CITY,KS 66103
来源：
CLINICAL PHARMACOKINETICS | 1978年 / 3卷 / 01期
关键词：
D O I：
10.2165/00003088-197803010-00001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1 / 13
页数：13
相关论文
共 75 条
[1]   PHARMACOKINETICS OF METHOTREXATE [J].
AZARNOFF, DL ;
WAN, SH ;
HUFFMAN, DH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1974, 16 (05) :884-885
[2]   POLYGAMMAGLUTAMYL METABOLITES OF METHOTREXATE [J].
BAUGH, CM ;
KRUMDIECK, CL ;
NAIR, MG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1973, 52 (01) :27-34
[3]   INDUCTION OF DIHYDROFOLIC REDUCTASE ACTIVITY IN LEUKOCYTES AND ERYTHROCYTES OF PATIENTS TREATED WITH AMETHOPTERIN [J].
BERTINO, JR ;
GABRIO, BW ;
DONOHUE, DM ;
SILBER, R ;
SIMMONS, B ;
HUENNEKENS, FM .
JOURNAL OF CLINICAL INVESTIGATION, 1963, 42 (04) :466-&
[4]   NEUROTOXICITY AND ELEVATED CEREBROSPINAL-FLUID METHOTREXATE CONCENTRATION IN MENINGEAL LEUKEMIA [J].
BLEYER, WA ;
DRAKE, JC ;
CHABNER, BA .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (15) :770-773
[5]  
BOURKE RS, 1975, CANCER RES, V35, P110
[6]  
CAPIZZI RL, 1970, CANCER RES, V30, P1782
[7]  
CHABNER BA, 1975, CANCER CHEMOTH REP 3, V6, P1
[8]   THRESHOLD METHOTREXATE CONCENTRATION FOR IN-VIVO INHIBITION OF DNA-SYNTHESIS IN NORMAL AND TUMOROUS TARGET TISSUES [J].
CHABNER, BA ;
YOUNG, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (08) :1804-1811
[9]  
COHEN MH, 1976, CANCER, V38, P1556, DOI 10.1002/1097-0142(197610)38:4<1556::AID-CNCR2820380418>3.0.CO
[10]  
2-8
12345678